BioPharmaceuticals Australia Development Fund

BioPharmaceuticals Australia (BPA) is a government-backed project management company dedicated to advancing Australia's biologics manufacturing sector. Established in 2005, the organization played a central role in the development of the National Biologics Facility in Brisbane, which provides essential infrastructure for the production of complex biopharmaceuticals. BPA partnered with global CDMO leaders, such as Patheon (now part of Thermo Fisher Scientific), to operate this facility, ensuring that Australian researchers and biotech companies have access to world-class GMP manufacturing services. By facilitating the transition from laboratory research to clinical-scale production, BPA helps bridge the gap for local biomedical innovations. The company continues to act as a strategic link between government, academia, and the private sector to foster a sustainable biomanufacturing ecosystem in the region.